0001065949-19-000133.txt : 20190910 0001065949-19-000133.hdr.sgml : 20190910 20190910135454 ACCESSION NUMBER: 0001065949-19-000133 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190910 ITEM INFORMATION: Other Events FILED AS OF DATE: 20190910 DATE AS OF CHANGE: 20190910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICAL INNOVATION HOLDINGS, INC. CENTRAL INDEX KEY: 0001093248 STANDARD INDUSTRIAL CLASSIFICATION: SHIP & BOAT BUILDING & REPAIRING [3730] IRS NUMBER: 841469319 STATE OF INCORPORATION: CO FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27211 FILM NUMBER: 191084852 BUSINESS ADDRESS: STREET 1: 575 PHARR RD. NE #53191 CITY: ATLANTA STATE: GA ZIP: 30355-6000 BUSINESS PHONE: (404) 919-4838 MAIL ADDRESS: STREET 1: 575 PHARR RD. NE #53191 CITY: ATLANTA STATE: GA ZIP: 30355-6000 FORMER COMPANY: FORMER CONFORMED NAME: MEDINA INTERNATIONAL HOLDINGS, INC. DATE OF NAME CHANGE: 20050316 FORMER COMPANY: FORMER CONFORMED NAME: COLORADO COMMUNITY BRAODCASTING INC DATE OF NAME CHANGE: 19990813 8-K 1 mihi8ksept102019.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): September 10, 2019

 

MEDICAL INNOVATION HOLDINGS, INC.

(Exact name of Registrant as specified in its charter)

 

Colorado 000-27211 84-1469319
(State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (I.R.S. Employer Identification No.)

 

575 Pharr Rd, NE #53191, Atlanta, GA 30355-6000

(Address of Principal Executive Offices)

 

(404) 919-4838

(Registrant's Telephone Number, Including Area Code)

 

5805 State Bridge Road, Suite G-328, Duluth, GA 30097/(866) 883-3793

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each Class Trading Symbol Name of each exchange on which registered
N/A N/A N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging Growth Company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 
 

 

  ITEM 8.01 OTHER EVENTS

 

 

As of September 10, 2019, the Company’s current address 575 Pharr Rd, NE #53191, Atlanta, GA 30355-6000. The telephone number is (404) 919-4838.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Medical Innovation Holdings, Inc.

 

By:

 

/s/ Redgie Green

 

____________________

Redgie Green

Title: Interim CEO

Date: September 10, 2019